Data-driven startup Zephyr AI has raised $18.5 million in seed funding to advance precision medicine and drug discovery with machine learning.
The startup’s tech combines data from multiple sources, machine learning and analyses of structured biological networks and longitudinal outcomes to generate insights.
Those insights can then be used to develop tools to improve outcomes in patient care and research, according to the company.
